[1] |
el Darouti M, Abu el Ela M. Necrolytic acral erythema: a cutaneous marker of viral hepatitis C[J]. Int J Dermatol, 1996,35(4):252⁃256.
|
[2] |
Abdallah MA, Ghozzi MY, Monib HA, et al. Necrolytic acral erythema: a cutaneous sign of hepatitis C virus infection[J]. J Am Acad Dermatol, 2005,53(2):247⁃251. doi: 10.1016/j.jaad. 2005.04.049.
|
[3] |
El⁃Ghandour TM, Sakr MA, El⁃Sebai H, et al. Necrolytic acral erythema in Egyptian patients with hepatitis C virus infection[J]. J Gastroenterol Hepatol, 2006,21(7):1200⁃1206. doi: 10. 1111/j.1440⁃1746.2006.04316.x.
|
[4] |
Das A, Kumar P, Gharami RC. Necrolytic acral erythema in the absence of hepatitis C virus infection[J]. Indian J Dermatol, 2016,61(1):96⁃99. doi: 10.4103/0019⁃5154.174047.
|
[5] |
Pandit VS, Inamadar AC, Palit A. Seronegative necrolytic acral erythema: a report of two cases and literature review[J]. Indian Dermatol Online J, 2016,7(4):304⁃307. doi: 10.4103/2229⁃5178. 185464.
|
[6] |
Srisuwanwattana P, Vachiramon V. Necrolytic acral erythema in seronegative hepatitis C[J]. Case Rep Dermatol, 2017,9(1):69⁃73. doi: 10.1159/000458406.
|
[7] |
Nofal AA, Nofal E, Attwa E, et al. Necrolytic acral erythema: a variant of necrolytic migratory erythema or a distinct entity?[J]. Int J Dermatol, 2005,44(11):916⁃921. doi: 10.1111/j.1365⁃4632.2004.02232.x.
|
[8] |
Raphael BA, Dorey⁃Stein ZL, Lott J, et al. Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection[J]. J Am Acad Dermatol, 2012,67(5):962⁃968. doi: 10.1016/j.jaad.2011.11.963.
|
[9] |
Fielder LM, Harvey VM, Kishor SI. Necrolytic acral erythema: case report and review of the literature[J]. Cutis, 2008,81(4):355⁃360.
|
[10] |
Zalewski PD, Forbes IJ, Giannakis C. Physiological role for zinc in prevention of apoptosis (gene⁃directed death)[J]. Biochem Int, 1991,24(6):1093⁃1101.
|
[11] |
Ingenbleek Y, Van Den Schrieck HG, De Nayer P, et al. The role of retinol⁃binding protein in protein⁃calorie malnutrition[J]. Metabolism, 1975,24(5):633⁃641.
|
[12] |
de Carvalho Fantini B, Matsumoto FY, Arnone M, et al. Necrolytic acral erythema successfully treated with oral zinc[J]. Int J Dermatol, 2008,47(8):872⁃873. doi: 10.1111/j.1365⁃4632. 2008.03597.x.
|
[13] |
Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C[J]. J Viral Hepat, 2001,8(5):367⁃371.
|
[14] |
Yost JM, Boyd KP, Patel RR, et al. Necrolytic acral erythema[J]. Dermatol Online J, 2013,19(12):20709.
|
[15] |
Bentley D, Andea A, Holzer A, et al. Lack of classic histology should not prevent diagnosis of necrolytic acral erythema[J]. J Am Acad Dermatol, 2009,60(3):504⁃507. doi: 10.1016/j.jaad. 2008.08.046.
|
[16] |
Abdallah MA, Ghozzi MY, Monib HA, et al. Histological study of necrolytic acral erythema[J]. J Ark Med Soc, 2004,100(10):354⁃355.
|
[17] |
Feldmann R, Wahl S, Steiner A. Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema[J]. J Eur Acad Dermatol Venereol, 2018,doi: 10.1111/jdv.14852.
|
[18] |
Khanna VJ, Shieh S, Benjamin J, et al. Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc[J]. Arch Dermatol, 2000,136(6):755⁃757.
|
[19] |
Hivnor CM, Yan AC, Junkins⁃Hopkins JM, et al. Necrolytic acral erythema: response to combination therapy with interferon and ribavirin[J]. J Am Acad Dermatol, 2004,50(5 Suppl):S121⁃124. doi: 10.1016/j.jaad.2003.09.017.
|
[20] |
Najarian DJ, Lefkowitz I, Balfour E, et al. Zinc deficiency associated with necrolytic acral erythema[J]. J Am Acad Dermatol, 2006,55(5 Suppl):S108⁃S110. doi: 10.1016/j.jaad.2005. 09.044.
|
[21] |
Moneib HA, Salem SA, Darwish MM. Evaluation of zinc level in skin of patients with necrolytic acral erythema[J]. Br J Dermatol, 2010,163(3):476⁃480. doi: 10.1111/j.1365⁃2133.2010. 09820.x.
|